Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

[HPV test replaces Pap test in Uppsala].

Olovsson M, Aarnio R, Rezapour M, Segeblad B, Sjöö EL, Wilander E.

Lakartidningen. 2013 Mar 26-Apr 9;110(13-14):695-6. Swedish. No abstract available.

PMID:
23634626
2.

Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.

Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU.

Ann Intern Med. 2011 Nov 15;155(10):687-97, W214-5. doi: 10.7326/0003-4819-155-10-201111150-00376. Epub 2011 Oct 17. Review. Erratum in: Ann Intern Med. 2012 Jan 3;156(1 Pt 1):71-2.

PMID:
22006930
3.

Testing for cervical cancer: new recommendations from the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology.

[No authors listed]

CA Cancer J Clin. 2012 May-Jun;62(3):211-2. doi: 10.3322/caac.21135. Epub 2012 Mar 14. No abstract available.

4.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Chinese.

PMID:
16635326
5.

Toward objective cervical cancer screening: maybe the eyes do have it.

Stoler MH.

Am J Clin Pathol. 2010 Jul;134(1):5-6. doi: 10.1309/AJCP6OORTVEZRK7Y. No abstract available.

PMID:
20551259
6.

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.

J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.

PMID:
19141778
7.

Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.

Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV.

Cancer Causes Control. 2003 Aug;14(6):505-12.

PMID:
12948281
8.

HPV test shows low sensitivity of Pap screen in older women.

Gyllensten U, Lindell M, Gustafsson I, Wilander E.

Lancet Oncol. 2010 Jun;11(6):509-10; author reply 510-1. doi: 10.1016/S1470-2045(10)70064-4. No abstract available.

PMID:
20522375
9.

HPV testing in cervical screening.

Cuzick J.

Pharmacoepidemiol Drug Saf. 2001 Jan-Feb;10(1):33-6. Review. No abstract available.

PMID:
11417064
10.

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.

Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J; Morelos HPV Study Collaborators.

Salud Publica Mex. 2002 Jul-Aug;44(4):335-44.

PMID:
12216521
11.

Extended duration of the detectable stage by adding HPV test in cervical cancer screening.

van den Akker-van Marie ME, van Ballegooijen M, Rozendaal L, Meijer CJ, Habbema JD.

Br J Cancer. 2003 Nov 17;89(10):1830-3.

12.

New cervical cancer screening strategy: combined Pap and HPV testing.

Jin XW, Zanotti K, Yen-Lieberman B.

Cleve Clin J Med. 2005 Feb;72(2):141-8.

PMID:
15757169
13.

Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J.

N Engl J Med. 2007 Oct 18;357(16):1589-97. Erratum in: N Engl J Med. 2008 Oct 9;359(15):1637. Johansson, Bo [added].

14.

Screening based on papillomavirus detection: too many false alarms.

[No authors listed]

Prescrire Int. 2010 Aug;19(108):178-9.

PMID:
20939456
15.

[Impact of HPV testing on cervical cancer screening].

Li G.

Zhonghua Fu Chan Ke Za Zhi. 2015 Apr;50(4):241-5. Chinese. No abstract available.

PMID:
26080933
16.

Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.

Gyllensten U, Sanner K, Gustavsson I, Lindell M, Wikström I, Wilander E.

Br J Cancer. 2011 Aug 23;105(5):694-7. doi: 10.1038/bjc.2011.277. Epub 2011 Aug 2.

17.

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.

J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.

PMID:
19903804
18.

Primary high-risk HPV screening for cervical cancer in post-menopausal women.

Gyllensten U, Gustavsson I, Lindell M, Wilander E.

Gynecol Oncol. 2012 May;125(2):343-5. doi: 10.1016/j.ygyno.2012.01.036. Epub 2012 Jan 28.

PMID:
22293044
19.

Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.

Monsonego J, Pintos J, Semaille C, Beumont M, Dachez R, Zerat L, Bianchi A, Franco E.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):591-8.

PMID:
16681731
20.

Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force.

Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, Lutz K.

Ann Intern Med. 2011 Nov 15;155(10):698-705, W216. doi: 10.7326/0003-4819-155-10-201111150-00377. Epub 2011 Oct 17. Review.

PMID:
22006929

Supplemental Content

Support Center